The Desert Research Institute (DRI) has entered into agreement with Magee Scientific of Berkeley, California, and its European partner company Aerosol of Ljubljana, Slovenia, to manufacture and market ...
The refined disease risk index (DRI) is a powerful prognostic model based solely on the disease type and stage for predicting survival outcomes of various hematological malignancies after allogeneic ...
The following is a summary of “A Novel Prognostic Calculator Model Predicting Diabetes Remission Before and After Metabolic Procedures,” published in the February 2025 issue of Annals of Surgery by ...